Advertisement

U.S. Senate Confirms Infection Expert as New CDC Director

0
By Carole Tanzer Miller HealthDay Reporter WEDNESDAY, July 30, 2025 (HealthDay News) — After months with an appointed caretaker, the U.S. Centers for Disease Control...

COVID-19 Vaccine Boosters Aid Outcomes in Patients With Cancer

0

Boosters tied to significant protection from severe COVID-19

Boy Dies From Brain-Eating Amoeba After Swimming in S.C. Lake

0
By I. Edwards HealthDay Reporter MONDAY, July 28, 2025 (HealthDay News) — A 12-year-old South Carolina boy has died after being infected by a rare,...

Consensus Offers Best Practices for Post-COVID-19 Residual Abnormalities on Chest CT

0

Term 'post-COVID-19 residual lung abnormality' should be used instead of 'interstitial lung abnormality' for describing post-COVID-19 abnormalities

U.S. to Remove Mercury Preservative From Flu Jabs

0
By Denise Mann HealthDay Reporter FRIDAY, July 25, 2025 (HealthDay News) — It's official: The controversial preservative thimerosal will be stripped from all flu vaccines distributed...

More Than Half of Infants Diagnosed With HIV Did Not Receive Postnatal HIV Prophylaxis

0

Researchers say findings point to gaps in prenatal HIV detection; the majority of infants not treated for HIV infection after birth were Black

More Than 110,000 Rich’s Ice Cream Bars Recalled Due to Listeria Risk

0
By Denise Mann HealthDay Reporter WEDNESDAY, July 23, 2025 (HealthDay News) — More than 100,000 Rich's Ice Cream Co. bars have been recalled due to...

Tuna Recalled in Seven States Over Listeria Fears

0
By Denise Mann HealthDay Reporter WEDNESDAY, July 23, 2025 (HealthDay News) — Two types of tuna sold in seven states are being recalled due to listeria concerns.The...

Shortened BDLC Regimen Not Noninferior for Drug-Resistant TB

0

Six or nine months of bedaquiline, delamanid, linezolid, and clofazimine was not noninferior to longer standard of care

35 Percent of Eligible Children Receive RSV Prophylaxis With Nirsevimab

0

Older age, Black race, very low Child Opportunity Index, public insurance linked to lower rates of nirsevimab receipt